# IMMUNOMEDICS INC (IMMU)

> Institutional ownership reported to the SEC as of Q3 2021, from Form 13F filings. Source: https://holderbook.com/stocks/IMMU/

- Reporting holders: 1
- Reported value: $15.0K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Neo Ivy Capital Management](https://holderbook.com/funds/1727783-neo-ivy-capital-management/) | $15.0K | 430 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2021 | 1 | $15.0K |
| Q3 2020 | 416 | $18.0B |
| Q2 2020 | 318 | $7.6B |
| Q1 2020 | 226 | $2.5B |
| Q4 2019 | 252 | $3.8B |
| Q3 2019 | 212 | $2.3B |
| Q2 2019 | 208 | $2.5B |
| Q1 2019 | 216 | $3.5B |
| Q4 2018 | 211 | $2.6B |